Power Wind Health Industry Incorporated AI Stock Analysis
Power Wind Health Industry Incorporated (8462) AI Stock Analysis
Power Wind Health Industry Incorporated
(TWSE:8462)
Strong financial performance from revenue growth and cash generation is the primary positive driver, supported by reasonable valuation, while technical indicators reflect short-term weakness.
Power Wind Health Industry Incorporated (8462) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 12.02B
- Dividend Yield
- 4.97%
- Average Volume (3M)
- 128.10K
- Price to Earnings (P/E)
- 12.7
- Beta (1Y)
- 0.14
- Revenue Growth
- 19.42%
- EPS Growth
- 56.90%
- Country
- TW
- Employees
- 445
- Sector
- General
- Sector Strength
- 55
- Industry
- Leisure
Power Wind Health Industry Incorporated Business Overview & Revenue Model
Company Description
Power Wind Health Industry Inc. operates a network of membership-based fitness clubs and recreational sports facilities throughout Taiwan, offering a range of related athletic services. Its offerings include comprehensive sports training programs. Es...
Power Wind Health Industry Incorporated Financial Statement Overview
Summary
Strong revenue growth, expanding margins, and robust cash flow generation support solid performance, though high leverage on the balance sheet remains a risk.
Income Statement
87Very PositiveBalance Sheet
52NeutralCash Flow
85Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.64B | 6.07B | 5.12B | 4.30B | 3.61B | 2.61B |
| Gross Profit | 2.22B | 1.94B | 1.45B | 1.03B | 829.51M | 328.69M |
| EBITDA | 2.32B | 2.15B | 1.73B | 1.34B | 1.19B | 803.30M |
| Net Income | 843.61M | 666.00M | 370.37M | 112.14M | 71.01M | -142.32M |
Balance Sheet | ||||||
| Total Assets | 12.89B | 11.99B | 10.64B | 10.09B | 9.34B | 8.17B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 1.80B | 1.40B | 1.23B | 1.21B | 1.12B |
| Total Debt | 7.67B | 7.52B | 6.96B | 7.05B | 6.43B | 5.42B |
| Total Liabilities | 10.47B | 9.61B | 8.60B | 8.31B | 7.63B | 6.51B |
| Stockholders Equity | 2.41B | 2.36B | 2.02B | 1.77B | 1.70B | 1.66B |
Cash Flow | ||||||
| Free Cash Flow | 1.88B | 1.55B | 1.32B | 861.26M | 710.65M | 88.11M |
| Operating Cash Flow | 2.55B | 2.22B | 1.94B | 1.47B | 1.19B | 820.14M |
| Investing Cash Flow | -685.42M | -678.11M | -735.86M | -604.72M | -479.98M | -743.13M |
| Financing Cash Flow | -821.17M | -1.23B | -1.12B | -851.11M | -662.93M | 54.95M |
Power Wind Health Industry Incorporated Peers Comparison
Overall Rating
TW:170773Outperform
TW:846268Neutral
TW:843662Neutral
TW:694540Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | TWD 11.75B | 10.96 | ― | 7.62% | -5.38% | -12.85% | |
| 68Neutral | TWD 12.09B | 12.67 | ― | 4.97% | 19.42% | 56.90% | |
| 62Neutral | TWD 10.68B | 10.48 | ― | 6.58% | -3.82% | 2.23% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 40Underperform | TWD 11.22B | -21.76 | ― | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:8462 | Power Wind Health Industry Incorporated | 146.50 | -0.69 | -0.47% | |
| TW:1707 | Grape King Bio Ltd. | 78.70 | -44.33 | -36.03% | |
| TW:6748 | ACRO Biomedical Co., Ltd. | 169.50 | 111.12 | 190.35% | |
| TW:6945 | AP Biosciences, Inc. | 117.50 | 7.00 | 6.33% | |
| TW:7780 | Daiken Biomedical Co., Ltd. | 15.10 | -2.15 | -12.45% | |
| TW:8436 | TCI Co., Ltd. | 91.40 | -22.40 | -19.68% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
